Table A1.
Compound | Chemical Group | Regulation Status | Drinking Water Value |
---|---|---|---|
Atenolol | β-Blockers | NORMAN framework prioritization 1 | N/A |
Azithromycin | Macrolide Antibiotic |
EU Watch List | N/A |
Clarithromycin | EU Watch List | N/A | |
Erythromycin | EU Watch List | N/A | |
Caffeine | Stimulant | NORMAN framework prioritization | N/A |
Carbamazepine | Anticonvulsant | NORMAN framework prioritization | N/A |
Ciprofloxacin | Fluoroquinolones antibiotics |
NORMAN framework prioritization | N/A |
Ofloxacin | NORMAN framework prioritization | N/A | |
Cyclophosphamide | Alkylating agent | NORMAN framework prioritization | N/A |
Diclofenac | Analgesics anti-inflammatory drugs |
EU Watch List | N/A |
Ketoprofen | NORMAN framework prioritization | N/A | |
Ibuprofen | NORMAN framework prioritization | N/A | |
Sulfamethoxazole | Antibacterial sulfonamides | NORMAN framework prioritization | N/A |
Trimethoprim | NORMAN framework prioritization | N/A | |
17-beta Estradiol | Estrogens | EU Watch List | 1 ng/L (reference value) |
Estrone | NORMAN framework prioritization | N/A |
1https://www.norman-network.net/ (accessed on 04 September 2019).